Delivery Order SPE2DB20D1100-SPE2DB25FC1L8

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The $1,702.34 firm fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, through its Corporate Office Division, will provide these prescription medications to support military treatment facilities and other federal healthcare programs. This delivery order is part of a...
This is a $4,675.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The order has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The $1,126.24 firm fixed price contract has an ultimate completion date of October 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a $1,517.16 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has a ceiling value of $2,350.38 and is a firm fixed price delivery order, with a completion date of July 26, 2024. The contract was not set aside for any specific business type....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The award has a ceiling value of $1,861.78 and an ultimate completion date of April 1, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The firm-fixed-price contract, valued at $1,705.58, has an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,579.19 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,008.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BRIVIACT 100 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC1L8
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The contract has a ceiling value of $1,354.81 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside.

Generated 8/10/25, 1:22 AM